Two Sigma Securities’s Pyxis Oncology PYXS Stock Holding History

Two Sigma Securities’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,474	Closed	-$19.7K	–	2234
2026 Q1	$19.7K	Buy	+13,474	New	+$20.3K	﹤0.01%	1372

Other funds holding PYXS

GGI

GordonMD Global Investments Beverely Hills, California $207M AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Securities's PYXS Position: Q2 2026 in Review

Two Sigma Securities sold out of Pyxis Oncology (PYXS) in Q2 2026, closing a stake of 13,474 shares — an estimated $19.7K sold.

Two Sigma Securities first reported a position in PYXS in Q1 2026 and held it in 1 quarter. The position peaked at $19.7K in Q1 2026. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

Two Sigma Securities reported no remaining Pyxis Oncology position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 13,474 Pyxis Oncology shares in Q2 2026, an estimated $19.7K.
Two Sigma Securities first reported a position in Pyxis Oncology in Q1 2026 and held it in 1 quarter.
Two Sigma Securities's Pyxis Oncology position peaked at $19.7K in Q1 2026.
76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.